References
- Beck L. R., Cowsar D. R., Lewis D. H., Cosorove R. J., Jr., Riddle C. T., Lowry S. L., Epperly T. A new long-acting injectable microcapsule system for the administration of progesterone. Fertility and Sterility 1979; 31: 545–551
- Beck L. R., Tice T. R. Poly(lactic acid) and poly(lactic acid-co-glycolic acid) contraceptive delivery systems. Long-acting Steroid Contraception, D. R. Mishell, Jr. Raven Press, New York 1983; 175–199
- Bygdeman M., Samuelsson B. Analyses of prostaglandins in human semen, prostaglandins and related factors 44. Clinica Chimica Acta 1966; 13: 465–474
- Chang T. M. S. Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines and other biologicals. Journal of Bioengineering 1976; 1: 25–32
- Microencapsulation and Artificial Cells, T. M. S. Chang. Human Press, New York 1984
- Chawla A. S., Chang T. M. S. In-vivo degradation of poly(lactic acid) of different molecular weights. Biomaterials, Medical Devices and Artificial Organs 1985; 13: 153–162
- Microencapsulation and Related Drug Processes, P. B. Deasy. Marcel Dekker, New York 1984; 3–8
- Demers L. M. Prostaglandins in human disease. Clinics in Laboratory Medicine 1984; 4: 787–801
- Dixit V., Chang T. M. S. Effects of prostaglandin E2 on the survival time of fulminant hepatic failure rats. International Journal of Artificial Organs 1982; 5: 588
- Dixit V., Chang T. M. S. Preliminary report on the effects of prostaglandin E2 on brain edema in fulminant hepatic failure rats. International Journal of Artificial Organs 1985; 8: 55–56
- Garrity M. J., Brass E. P., Robertson R. P. Kinetics of prostaglandin E metabolism in isolated hepatocytes. Biochimica et Biophysica Acta 1984; 796: 136–141
- Hamberg M., Samuelsson B. On the metabolism of prostaglandin E1 and E2 in man. Journal of Biological Chemistry 1971; 246: 6713–6721
- Higuchi T. Rate of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961; 50: 874–875
- Jumi K., Ogata J., Matsui N., Kubota M., Nakano M. Control of release rate bleomycin from polylactic acid microspheres by additives. Chemical and Pharmaceut ical Bulletin 1985; 33: 1609–1614
- Kulkarni R. K., Moore E. G., Hegyeli A. F., Leonard F. Biodegradable poly(lactic acid) polymers. Journal of Biomedical Materials Research 1971; 5: 169–181
- Monkhouse D. C., Campen L. V., Aguiar A. J. Kinetics of dehydration and isomerization prostaglandins E1 and E2. Journal of Pharmaceutical Sciences 1973; 62: 576–580
- Smith A., Hunneyball I. M. Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration. International Journal of Pharma ceutics 1986; 30: 215–220
- Visscher G. E., Robison R. L., Maulding H. V., Fong J. W., Pearson J. E., Argentieri G. J. Note: Biodegradation of and tissue reaction to poly(D,L-lactide) microcapsules. Journal of Biomedical Materials Research 1986; 20: 667–676
- Wakiyama N., Juni K., Nakano M. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release of microspheres containing local anaesthetics. Chemical and Pharmaceutical Bulletin 1982; 30: 2621–2628